Sawant; Sanghapal Damodhar
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sawant; Sanghapal Damodhar.The latest application filed is for "pyrazolopyrimidinones for the treatment of impotence and process for the preparation thereof".
- Sawant; Sanghapal Damodhar - Jammu IN
- Sawant; Sanghapal Damodhar - Jammu Tawi N/A IN
| Patent | Date |
|---|---|
| 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof Grant 9,845,330 - Singh , et al. December 19, 2 | 2017-12-19 |
| Pyrazolopyrimidinones for the treatment of impotence and process for the preparation thereof App 20170066771 - SAWANT; Sanghapal Damodhar ; et al. | 2017-03-09 |
| 6-NITRO-2,3-DIHYDROIMIDAZO[2,1-b]OXAZOLES AND A PROCESS FOR THE PREPARATION THEREOF App 20160244462 - SINGH; Parvinder Pal ; et al. | 2016-08-25 |
| Boronic acid bearing liphagane compounds as inhibitors of P13K-.alpha. and/or .beta. Grant 9,206,201 - Vishwakarma , et al. December 8, 2 | 2015-12-08 |
| BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF P13K- a AND/OR B App 20150051173 - Vishwakarma; Ram Asrey ; et al. | 2015-02-19 |
| Spiro derivatives of parthenin as novel anticancer agents Grant 8,609,858 - Halmuthur , et al. December 17, 2 | 2013-12-17 |
| Spiro Derivatives of Parthenin as Novel Anticancer Agents App 20110201661 - Halmuthur; Mahabalarao Sampath Kumar ; et al. | 2011-08-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 